The Financial Times announces it will be hosting the Global Pharmaceutical and Biotechnology Conference in London on 2 and 3 December 2008

Sponsored by Deloitte the conference will take place at The Cumberland Hotel and will discuss how the pharmaceutical and life science industry can benefit from the emerging opportunities for growth in the years ahead.

The increase in life expectancy, population growth, the appearance of new diseases and the significant changes in the way that healthcare is delivered, constitute opportunities which the industry must harness in order to increase value for shareholders and investors, and boost productivity and performance. The conference is an opportunity for delegates to hear outstanding speakers discussnew perspectives, ‘feel the pulse’ of the industry and network with peers across the sector.  Finally Andrew Jack, Pharmaceuticals Correspondent at the Financial Times, will conduct live interview with three CEOs.

Confirmed Speakers of the FT Global Pharmaceutical and Biotechnology Conference include: 

Angus Russell, Chief Executive Officer, Shire Pharmaceuticals Group PLC

Bob Go, Global Life Sciences and Health Care Industry Leader, Deloitte Touche Tohmatsu

David Brennan, Chief Executive Officer, AstraZeneca PLC 

Joe Jimenez, Chief Executive Officer, Pharmaceutical, Novartis International AG

Jon Symonds, Managing Director, Goldman Sachs International 

Stefano Passina, Executive Chairman, Alliance Boots GmBH

Wayne Gattinella, President and CEO, WebMD 

William M. Burns, Chief Executive Officer, Roche Pharmaceutical Division

Further information about the conference can be found online at: http://www.ftpharmabiotech.com/

Please contact Lysandra Sokkou on +44 (0) 20 7873 4874 or lysandra.sokkou@ft.com to arrange media passes to the FT Pharmaceutical and Biotechnology Conference for accredited media.